Sumitomo Pharma America, Inc., a subsidiary of Sumitomo Pharma Co., Ltd., is headquartered in the United States and operates primarily in North America. Founded in 2005, the company has established itself within the pharmaceutical industry, focusing on innovative treatments in areas such as central nervous system disorders, oncology, and infectious diseases. With a commitment to research and development, Sumitomo Pharma America offers unique products that address unmet medical needs, leveraging advanced technologies and scientific expertise. The company has achieved significant milestones, including strategic partnerships and the successful launch of several key therapies, solidifying its position in the competitive pharmaceutical landscape. Through its dedication to improving patient outcomes, Sumitomo Pharma America continues to make a notable impact in the healthcare sector.
We don't have data for Sumitomo Pharma America, Inc., but we can show you information about their parent organization instead.
View parent company